Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
J Eur Acad Dermatol Venereol ; 31(1): 142-150, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27501029

ABSTRACT

BACKGROUND: Overexpression or administration of interleukin 31 (IL-31) has been shown to induce a profound itch response in mice and dogs. The chronic pruritus observed in mouse IL-31 transgenic mice results in the development of skin lesions and alopecia through excoriation from excessive scratching, a condition similar to that observed in patients with atopic dermatitis (AD). OBJECTIVE: To test whether IL-31 induces pruritus in non-human primates and, if so, whether treatment with an anti-IL-31 neutralizing monoclonal antibody (mAb) can block the response. METHODS: A series of studies was conducted in cynomolgus monkeys to evaluate the itch response to recombinant cynomolgus IL-31 (cIL-31) administration. Three routes of cIL-31 administration (intravenous, intradermal, and subcutaneous) were evaluated. Subcutaneous treatment with a humanized anti-human IL-31 mAb cross-reactive to cIL-31 was subsequently tested for its ability to block the response to intradermal cIL-31 administration. RESULTS: Each route of cIL-31 delivery elicited a scratching response immediately after cIL-31 administration and lasted at least 3 h. Treatment with the IL-31 mAb inhibited the cIL-31-mediated scratching response in a dose-dependent manner. CONCLUSION: These results demonstrate that an IL-31 mAb can inhibit IL-31-mediated pruritus in vivo, and could be an effective therapy for pruritic skin conditions like AD where IL-31 upregulation may play a role.


Subject(s)
Interleukins/administration & dosage , Animals , Humans , Interleukins/immunology , Macaca fascicularis , Mice , Neutralization Tests
2.
Clin Exp Allergy ; 38(12): 1959-68, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19037968

ABSTRACT

BACKGROUND: Increased levels of serum IgE are associated with greater asthma prevalence and disease severity. IgE depletion using an anti-IgE monoclonal antibody has met with success in the treatment of moderate-to-severe and severe persistent allergic asthma. OBJECTIVE: To test whether B cell-targeted therapy is a more effective treatment for airway hyperresponsiveness (AHR) in a murine model compared with IgE-depletion. METHODS: We delivered soluble mTACI-Ig, a receptor for the B cell survival factors BLyS (B Lymphocyte Stimulator) and APRIL (A PRoliferation-Inducing Ligand), or anti-IgE to allergen-sensitized mice before airway challenge with allergen. RESULTS: mTACI-Ig treatment reduced circulating mature B cell levels in the blood, while anti-IgE treatment had no effect on B cell counts. Both mTACI-Ig and anti-IgE decreased the levels of total and allergen-specific IgE in the serum. Histopathologic analysis of lungs showed a reduction in disease severity scores for both treatment groups, but results were more pronounced in mTACI-Ig-treated mice. Neutrophil and eosinophil numbers in the bronchoalveolar lavage (BAL) were significantly reduced following mTACI-Ig treatment, but not after anti-IgE delivery. BLyS and APRIL blockade also resulted in a significant decrease in IL-4 and eotaxin mRNA and IL-4 and KC protein levels in total lung homogenates and BAL fluid, respectively. Finally, mTACI-Ig treatment was more effective than anti-IgE treatment in reducing AHR to inhaled antigen. CONCLUSIONS: Our data demonstrate that delivery of mTACI-Ig is a more effective treatment than anti-IgE mAb in a murine model of AHR.


Subject(s)
Asthma/prevention & control , Recombinant Fusion Proteins/therapeutic use , Allergens/adverse effects , Animals , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/therapeutic use , Asthma/blood , Asthma/etiology , Asthma/immunology , B-Cell Activating Factor/genetics , B-Lymphocytes/immunology , Bronchoalveolar Lavage Fluid/immunology , Chemokines/genetics , Chemokines/metabolism , Disease Models, Animal , Eosinophils/immunology , Immunoglobulin E/blood , Immunoglobulin E/immunology , Inflammation/pathology , Injections, Intraperitoneal , Interleukin-4/genetics , Interleukin-4/metabolism , Lung/metabolism , Lung/pathology , Mice , Mice, Inbred BALB C , Neutrophils/immunology , Ovalbumin/adverse effects , RNA, Messenger/genetics , Recombinant Fusion Proteins/administration & dosage , Tumor Necrosis Factor Ligand Superfamily Member 13/genetics
3.
Immunity ; 15(2): 289-302, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11520463

ABSTRACT

BLyS and APRIL have similar but distinct biological roles, mediated through two known TNF receptor family members, TACI and BCMA. We show that mice treated with TACI-Ig and TACI-Ig transgenic mice have fewer transitional T2 and mature B cells and reduced levels of circulating immunoglobulin. TACI-Ig treatment inhibits both the production of collagen-specific Abs and the progression of disease in a mouse model of rheumatoid arthritis. In BLyS-deficient mice, B cell development is blocked at the transitional T1 stage such that virtually no mature B cells are present, while B-1 cell numbers are relatively normal. These findings further elucidate the roles of BLyS and APRIL in modulating B cell development and suggest that BLyS is required for the development of most but not all mature B cell populations found in the periphery.


Subject(s)
Autoimmune Diseases/etiology , B-Lymphocytes/immunology , Membrane Proteins , Receptors, Tumor Necrosis Factor/metabolism , Animals , Antibody Formation , Arthritis, Rheumatoid/etiology , Arthritis, Rheumatoid/immunology , Autoantibodies/blood , B-Cell Activation Factor Receptor , B-Lymphocytes/classification , Cell Differentiation , Cell Lineage , Collagen/immunology , Homozygote , Immunoglobulins/blood , Mice , Mice, Transgenic , Phenotype , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor/immunology , Transmembrane Activator and CAML Interactor Protein
4.
Biochim Biophys Acta ; 1492(2-3): 465-9, 2000 Jul 24.
Article in English | MEDLINE | ID: mdl-11004516

ABSTRACT

This paper reports on the cloning and characterization of a novel human ribonucleoprotein, RBM8, containing a single RNA binding domain comprising the two RNP-CS and RNP-2 consensus motifs. The protein has 55% identity to a segment of a C. elegans ribonucleoprotein of unknown function. The RBM8 gene shows ubiquitous tissue expression, predominantly as a 0.9 kb transcript. An interesting feature of the RBM8 transcript is an homology of 42% in the 3' untranslated region, in the antisense orientation, to the human gonadotropin-releasing hormone receptor polypeptide. RBM8 maps to human chromosome 14 in the 14q21-q23 region.


Subject(s)
RNA-Binding Proteins/genetics , Ribonucleoproteins/genetics , Amino Acid Sequence , Blotting, Northern , Cloning, Molecular , Gene Expression Regulation , Humans , Molecular Sequence Data , Protein Conformation , Sequence Homology, Amino Acid
5.
J Immunol ; 151(11): 6559-68, 1993 Dec 01.
Article in English | MEDLINE | ID: mdl-8245485

ABSTRACT

The DNA sequence of the mouse H chain V regions from five hybridomas directed against the human tumor Ag tumor-associated glycoprotein-72 (TAG-72) have been determined. This includes a previously determined VH gene sequence from a first-generation anti-TAG-72 mAb, B72.3, and the VH gene sequences from four second-generation anti-TAG-72 mAb, CC49, CC83, CC46, and CC92. A sequence comparison revealed a high degree of shared sequence identity between the five productively rearranged VH genes, suggesting derivation from a common germ line V region gene. In the process of cloning the unrearranged germ line gene, two highly related VH germ line genes were identified and designated VH alpha TAG-1 and VH alpha TAG-2. A comparison of the productively rearranged anti-TAG-72 VH sequences with the two germ line VH genes demonstrated that they were all derived from VH alpha TAG-1. In contrast, the L chain V regions are all derived from separate germ line V region genes. The preferential use of VH alpha TAG-1 in these five mouse hybridomas suggests that VH alpha TAG-1 is a preferred anti-TAG-72 H V chain region germ line gene and that the H chain plays a predominant role in the recognition of this Ag.


Subject(s)
Antibodies, Monoclonal/genetics , Antibodies, Neoplasm/genetics , Antigens, Neoplasm/immunology , Genes, Immunoglobulin , Glycoproteins/immunology , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/genetics , Amino Acid Sequence , Animals , Base Sequence , DNA/chemistry , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Polymerase Chain Reaction
6.
Biochemistry ; 29(18): 4393-400, 1990 May 08.
Article in English | MEDLINE | ID: mdl-1693523

ABSTRACT

Regulation of the human fetal (gamma) globin gene and a series of mutant gamma-globin genes was studied after retroviral transfer into erythroid cells with fetal or adult patterns of endogenous globin gene expression. Steady-state RNA from a virally transferred A gamma-globin gene with a normal promoter increased after induction of erythroid maturation of murine erythroleukemia cells and comprised from 2% to 23% of the mouse beta maj-globin RNA level. RNA expression from the virally transferred A gamma-globin gene comprised 23% of the endogenous G gamma- + A gamma-globin expression in K 562 cells after treatment with hemin. Expression from a virally transferred gamma- or beta-globin gene exceeded endogenous gamma- or beta-globin expression by a factor of 6 or more in the human erythroleukemia line KMOE, in which the endogenous globin genes are weakly inducible. In these experiments, no difference in expression was observed between the gene with the normal promoter and an A gamma-globin gene with a point mutation in its promoter (-196 C-to-T) that has been associated with hereditary persistence of fetal hemoglobin (HPFH). To test for cis-acting determinants located within the introns of the gamma-globin gene, expression was measured from a set of gamma-globin genes configured with either intron alone or with neither intron. In contrast to an intronless beta-globin gene, which is not expressed in MEL cells, the intronless gamma-globin gene was expressed in MEL cells at 24% of the level of an intron-containing gene.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Cell Transformation, Neoplastic , Genes , Globins/genetics , Retroviridae/genetics , Transfection , Animals , Cell Line , Cells, Cultured , Fetus , Gene Expression , Humans , Introns , Leukemia, Erythroblastic, Acute , Moloney murine leukemia virus/genetics , Mutation , Poly A/genetics , Promoter Regions, Genetic , RNA/genetics , RNA, Messenger
7.
Blood ; 71(4): 1108-12, 1988 Apr.
Article in English | MEDLINE | ID: mdl-2451548

ABSTRACT

A variant of hereditary persistence of fetal hemoglobin (HPFH), first described in a patient from Seattle, was studied by structural analysis of the gamma-globin genes. A family study suggested that the determinant for this form of HPFH, in which the HbF contains both G gamma- and A gamma-globin chains, segregated with the beta S gene. No deletions or other abnormalities were detected in the fetal to adult globin gene region by genomic mapping studies. All four gamma-globin genes were isolated from a cosmid library, and allelic pairs of gamma-globin genes were distinguished by linkage to either the beta S- or beta A-globin gene. Nucleotide sequence analysis of the four gamma-globin gene promoters revealed a total of three discrepancies compared with a reference sequence, but these were judged unlikely to be the underlying determinants. Sequence analysis of the enhancer region located 3' to the A gamma-globin gene from the putative HPFH chromosome revealed three base substitutions, whereas this region was normal in the A gamma-globin gene linked to the beta A gene. These data raise the possibility that an alteration of enhancer function rather than promoter function could be the basis for this condition.


Subject(s)
Enhancer Elements, Genetic , Fetal Hemoglobin/genetics , Hemoglobins, Abnormal/genetics , Promoter Regions, Genetic , Base Sequence , Cloning, Molecular , Globins/genetics , Humans , Male , Middle Aged , Molecular Sequence Data , Mutation , Pedigree
8.
Mol Cell Biol ; 8(2): 713-21, 1988 Feb.
Article in English | MEDLINE | ID: mdl-2451123

ABSTRACT

Single base substitutions have been identified in the promoter regions of A gamma-globin genes from individuals with certain types of nondeletion A gamma hereditary persistence of fetal hemoglobin (HPFH). The presence of these mutations is closely associated with the A gamma HPFH phenotype, but proof that they are the nondeletion HPFH determinants is lacking. To test directly whether these base substitutions can result in an increase in A gamma-globin gene transcription, we studied cosmid clones containing the G gamma- through beta-globin gene regions from individuals with Greek-type (G-to-A base substitution at -117) and Chinese-type (C-to-T base substitution at -196) A gamma HPFH in a transient expression assay. When tested as part of a cosmid clone, the Greek HPFH A gamma-globin gene consistently produced about 1.4 times as much RNA as the wild-type A gamma-globin gene when standardized against RNA transcribed from the G gamma genes in cis. The relative strengths of the normal and HPFH A gamma-globin gene promoters were also compared in transient expression assays with plasmids containing the A gamma-globin genes. Pseudo-wild-type A gamma-globin genes containing a short, transcriptionally neutral deletion were used so that two A gamma-globin genes that differed in their promoter sequences could be compared in the same transfection. The plasmid transient expression results indicated a 1.3- to 1.4-fold increase in steady-state RNA levels from the Greek-type A gamma HPFH promoter compared with the wild-type A gamma promoter, while no difference was documented between the Chinese-type A gamma HPFH promoter and the wild-type A gamma promoter.


Subject(s)
Fetal Hemoglobin/genetics , Genes , Globins/genetics , Mutation , Promoter Regions, Genetic , Cell Line , Chromosome Deletion , Cosmids , Fetus , Humans , Plasmids , Transcription, Genetic
10.
Biochemistry ; 24(8): 2077-86, 1985 Apr 09.
Article in English | MEDLINE | ID: mdl-2990550

ABSTRACT

A human genomic DNA library was screened for the gene coding for the gamma chain of fibrinogen by using a human cDNA for the gamma chain as a hybridization probe. The gene was identified in three overlapping recombinant lambda bacteriophage, and its sequence, including the immediate 5' and 3' flanking regions, was determined. The DNA sequence analysis revealed the presence of 10 exons coding for 411 amino acids present in the mature protein and a signal sequence of 26 amino acids. Two 30 base pair (bp) direct repeats of 93% identity were found 468 bp upstream from the transcription initiation site. The DNA sequence of the gene for the gamma chain of human fibrinogen showed considerable sequence homology with a partial sequence reported for the gene for the gamma chain of rat fibrinogen.


Subject(s)
Cloning, Molecular , Fibrinogen/genetics , Genes , Amino Acid Sequence , Bacteriophage lambda/genetics , Base Sequence , DNA/metabolism , DNA Restriction Enzymes , Humans , Nucleic Acid Hybridization , RNA, Messenger/genetics
11.
Biochemistry ; 22(13): 3237-44, 1983 Jun 21.
Article in English | MEDLINE | ID: mdl-6688355

ABSTRACT

A human liver cDNA library was screened for the alpha chain of fibrinogen with a cDNA clone from the corresponding bovine molecule as a hybridization probe. Several human clones coding for the alpha chain were identified, and one of these was used to rescreen the entire cDNA library of 18 000 recombinants. Plasmids with the largest cDNAs were isolated, and their inserts were sequenced. The largest cDNA insert contained 2224 base pairs, including a noncoding region at the 5'-end followed by a region coding for a signal peptide of 19 (or 16) amino acids and a mature protein of 625 amino acids, a stop codon of TAG, another noncoding region, and a poly(A) tail at the 3'-end. Eight tandem repeats of 39 base pairs were observed starting with nucleotide 905 (amino acid residue 270) and ending with nucleotide 1213 (amino acid residue 372). The identity in the nucleotide sequence in the tandem repeats ranged from 72 to 95% when compared to a consensus sequence. The predicted amino acid sequence for the mature polypeptide chain was 15 amino acids longer at the carboxyl-terminal end than that of the alpha chain isolated and sequenced from plasma fibrinogen. This indicates that minor proteolysis has taken place on the carboxyl-terminal end of the alpha chains, and this modification has probably occurred during secretion or circulation of the protein in plasma.


Subject(s)
Fibrinogen/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA/genetics , DNA, Recombinant , Humans , Liver/physiology , Macromolecular Substances , Mutation , Repetitive Sequences, Nucleic Acid
12.
Biochemistry ; 22(13): 3244-50, 1983 Jun 21.
Article in English | MEDLINE | ID: mdl-6688356

ABSTRACT

A total of 148 cDNAs coding for the beta chain of human fibrinogen have been identified from a human liver cDNA library employing a bovine cDNA as a probe. The largest cDNA insert contained 1932 base pairs cloned into the PstI site of plasmid pBR322. This cDNA insert contained 66 base pairs coding for a portion or all of a signal sequence, 1383 base pairs coding for 461 amino acids in the mature protein, a stop codon of TAG, a noncoding region of 431 base pairs, and a poly(A) tail of 19 base pairs. Most of the cDNA inserts coding for the beta chain were found to have a noncoding region of 98 or 167 base pairs rather than 431 base pairs at the 3'-end. The bovine cDNA for the beta chain was also employed as a probe for screening a lambda phage library containing human genomic DNA. Seven positive phage were identified. One of the phage, which contained the entire gene for the beta chain of fibrinogen, was examined by electron microscopy, and portions of its DNA sequence are presented. Seven intervening sequences were identified in the gene for the beta chain of human fibrinogen. The largest intervening sequence (approximately 1.3 kilobases) was found at the 5'-end of the gene and was located between amino acid residues 8 and 9, which are present in fibrinopeptide B. A sequence analysis of the 5'-end of the gene also indicated that the B chain of human fibrinogen contained a signal sequence of either 16, 27, or 30 amino acid residues.


Subject(s)
Fibrinogen/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA/genetics , DNA, Recombinant , Genes , Humans , Liver/physiology , Macromolecular Substances , Nucleic Acid Hybridization
13.
Ann N Y Acad Sci ; 408: 449-56, 1983 Jun 27.
Article in English | MEDLINE | ID: mdl-6575700

ABSTRACT

Cross-species hybridizations have enabled us to isolate and clone the gene for the beta chain of human fibrinogen. Highlights of the gene for the beta chain revealed by nucleotide sequence analyses, particularly in areas that have a direct bearing on defining the overall organization of the gene, have been presented. Nucleotide sequence determination has confirmed the presence of seven intervening sequences. The positions where several of these intervening sequences interrupt the coding region appear to be related to the functional domains of the polypeptide. A putative signal peptide has been identified. Studies on the cDNA for the human alpha chain indicate that the alpha chain polypeptide may be synthesized in a precursor form with a COOH-terminal extension of 15 amino acids as compared to the alpha chain present in the mature molecule found in plasma. We are in the process of isolating the genes for the alpha and gamma chains by a similar approach. We are hopeful that these studies will provide information as to how they are regulated and how they have undergone changes in the course of evolution.


Subject(s)
Cloning, Molecular , DNA/analysis , Fibrinogen/genetics , Amino Acid Sequence , Base Sequence , Humans , Microscopy, Electron , Nucleic Acid Conformation
14.
Proc Natl Acad Sci U S A ; 78(3): 1466-70, 1981 Mar.
Article in English | MEDLINE | ID: mdl-6262803

ABSTRACT

Recombinant plasmids containing bovine cDNA have been screened with a radiolabeled cDNA enriched for bovine fibrinogen. A number of plasmids containing cDNAs for fibrinogen were identified by this assay. One plasmid, designated pBI beta 1, was found to contain a cDNA insert of 1372 base pairs. The sequence of the cDNA insert for this plasmid was then determined. It was shown to code for 424 amino acids of the beta chain of fibrinogen, starting with residue 44. This and other data made it possible to construct the complete amino acid sequence of the beta chain of the protein. Comparison of the amino acid sequence of the beta chain of bovine fibrinogen with the corresponding chain of the human molecule indicated that the two chains are greater than 80% homologous.


Subject(s)
Cloning, Molecular , DNA, Recombinant , Fibrinogen/genetics , Amino Acid Sequence , Animals , Base Sequence , Cattle , DNA Restriction Enzymes , DNA, Recombinant/metabolism , Genetic Code , Humans , Macromolecular Substances , Nucleic Acid Hybridization , Plasmids , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...